RHHBY's data on experimental obesity drug, CT-996, disappoints investors on higher incidence of adverse events.
Vous n'êtes pas connecté
RHHBY's Accu-Chek Smartguide will provide several predictive features aimed at enhancing patient safety. However, the device may face tough competition from existing CGM devices.
RHHBY's data on experimental obesity drug, CT-996, disappoints investors on higher incidence of adverse events.
Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.
Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.
In an unprecedented move to enhance customer satisfaction and encourage loyalty, Apple has announced a remarkable offer for its iPhone 15 and iPhone...
Meta has launched new Instagram features aimed at enhancing safety for teens with stricter content controls and parental guidance.
Meta has launched new Instagram features aimed at enhancing safety for teens with stricter content controls and parental guidance.
WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...
WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...
SEVERAL construction firms and agencies from both the private and public sectors in Linden took part in an educational seminar Tuesday, aimed at...
Apple's iPhone 16 launch in China has sparked disappointment over lack of AI features, amid growing competition from Huawei.